|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02410 TYK MEDICINES-B
Nominal 
28.900 +1.850 (+6.839%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 |
| Property, plant, equip. & others | 159,575 | 1.311% | 157,510 | 82,648 |
| Land & other Lease Assets | 50,260 | -45.568% | 92,335 | 107,548 |
| Intangible Assets | 62,412 | -8.313% | 68,071 | 73,730 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 |
| Other Non-current Assets | 74,471 | 246.167% | 21,513 | 19,705 |
| 346,718 | 2.147% | 339,429 | 283,631 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | 0 | -- | 0 | 0 | |
| Trade Receivables | 0 | -- | 0 | 0 | |
| Cash & Bank Balances | 460,463 | 146.461% | 186,830 | 90,762 | |
| Other Current Assets | 76,175 | 62.493% | 46,879 | 183,968 | |
| Assets Held for Sale | 32,337 | -- | 0 | 0 | |
| 568,975 | 143.454% | 233,709 | 274,730 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | 19,642 | -38.937% | 32,167 | 9,664 | ||
| S-T Debt & Leases | 170,363 | 666.503% | 22,226 | 23,492 | ||
| Other Current Liabilities | 99,064 | -92.053% | 1,246,586 | 929,084 | ||
| Liab asso w/ Assets Held for Sale | 12 | -- | 0 | 0 | ||
| 289,081 | -77.780% | 1,300,979 | 962,240 | |||
| Net Current Assets | 279,894 | -- | (1,067,270) | (687,510) | ||
| Total Assets Less Current Liabilities | 626,612 | -- | (727,841) | (403,879) | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | 6,485 | -66.749% | 19,503 | 32,458 | |||
| Other Non-current Liabilities | 147,565 | 11.211% | 132,689 | 64,412 | |||
| 154,050 | 1.221% | 152,192 | 96,870 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | 370,836 | 20.654% | 307,356 | 287,989 | ||||
| Reserves | 98,252 | -- | (1,191,836) | (793,929) | ||||
| Others | 0 | -- | 0 | 0 | ||||
| Shareholders' Funds | 469,088 | -- | (884,480) | (505,940) | ||||
| Non-controlling Interests | 3,474 | -21.880% | 4,447 | 5,191 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| 472,562 | -- | (880,033) | (500,749) | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | 15,540 | 12,393 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -386,955,000 |
| %Change | 1.184% |
| EPS / (LPS) | RMB -1.150 |
| NBV Per Share (¥) | RMB 1.265 |